DK1147119T3 - 2,3-O-isopropylidenderivater af monosaccharider som celleadhæsionsinhibitorer - Google Patents
2,3-O-isopropylidenderivater af monosaccharider som celleadhæsionsinhibitorerInfo
- Publication number
- DK1147119T3 DK1147119T3 DK00900088T DK00900088T DK1147119T3 DK 1147119 T3 DK1147119 T3 DK 1147119T3 DK 00900088 T DK00900088 T DK 00900088T DK 00900088 T DK00900088 T DK 00900088T DK 1147119 T3 DK1147119 T3 DK 1147119T3
- Authority
- DK
- Denmark
- Prior art keywords
- monosaccharides
- cell adhesion
- adhesion inhibitors
- isopropylidene derivatives
- isopropylidene
- Prior art date
Links
- 230000021164 cell adhesion Effects 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 150000002772 monosaccharides Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
- C07H9/04—Cyclic acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Hospice & Palliative Care (AREA)
- Surgery (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN86DE1999 IN190975B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1999-01-15 | 1999-01-15 | |
US09/276,368 US6590085B1 (en) | 1999-01-15 | 1999-03-25 | Derivatives of monosaccharides as cell adhesion inhibitors |
PCT/IB2000/000022 WO2000042054A1 (en) | 1999-01-15 | 2000-01-10 | 2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1147119T3 true DK1147119T3 (da) | 2004-01-19 |
Family
ID=11088155
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00900088T DK1147119T3 (da) | 1999-01-15 | 2000-01-10 | 2,3-O-isopropylidenderivater af monosaccharider som celleadhæsionsinhibitorer |
Country Status (30)
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN190975B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1999-01-15 | 2003-09-06 | Ranbaxy Lab Ltd | |
KR20060021870A (ko) | 2003-05-30 | 2006-03-08 | 랜박시 래보러터리스 리미티드 | 치환된 피롤 유도체와 hmg―co 억제제로서의 이의용도 |
EP1789428A1 (en) * | 2004-09-02 | 2007-05-30 | Ranbaxy Laboratories Limited | Monosaccharide derivatives |
EP1902063A2 (en) * | 2004-12-22 | 2008-03-26 | Ranbaxy Laboratories Limited | Derivatives of pentose monosaccharides as anti-inflammatory compounds |
WO2007010499A2 (en) * | 2005-07-22 | 2007-01-25 | Ranbaxy Laboratories Limited | Derivatives of monosaccharides for the treatment of copd and allergic rhinitis |
BRPI0618379A2 (pt) * | 2005-11-08 | 2011-08-30 | Ranbaxy Lab Ltd | processo para preparação do hemi-sal de cálcio do ácido (3r,5r) -7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroxime tilfenilamino) carbonil]-pirrol-1-il] -3, 5-diidroxi heptanóico |
TW200744583A (en) * | 2006-03-14 | 2007-12-16 | Ranbaxy Lab Ltd | Statin stabilizing dosage formulations |
EP1842855A3 (en) * | 2006-03-29 | 2007-12-05 | Ranbaxy Laboratories Limited | Monosaccharide derivatives as anti-inflammatory and/or anti-cancer agents |
US7790689B2 (en) * | 2006-05-30 | 2010-09-07 | Ranbaxy Laboratories Limited | Monosaccharide derivatives |
US20080300196A1 (en) * | 2006-10-03 | 2008-12-04 | Ashwani Kumar Verma | Monosaccharide derivatives |
US10034995B2 (en) * | 2007-09-20 | 2018-07-31 | Resmed Limited | Retractable tube for CPAP |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2715121A (en) | 1950-09-09 | 1955-08-09 | American Home Prod | Alkyl sugar derivatives and their preparation |
US4056322A (en) | 1973-12-14 | 1977-11-01 | Strategic Medical Research Corporation | Preparation of ethers of monosaccharides |
US4735934A (en) | 1981-02-17 | 1988-04-05 | Greenwich Pharmaceuticals Incorporated | Method of therapeutically treating a warm blooded animal afflicted with an autoimmune disease |
US4996195A (en) | 1989-01-09 | 1991-02-26 | Greenwich Pharmaceuticals Inc. | Derivatives of α,D-glucofuranose or α,D-allofuranose and intermediates for preparing these derivatives |
US5010058A (en) | 1989-06-22 | 1991-04-23 | 501 Greenwich Pharmaceuticals Incorporated | 3,5,6-substituted derivatives of 1,2-O-isopropylidene-α,D-glucofuranose and intermediates for preparing these derivatives |
FR2652540B1 (fr) | 1989-10-02 | 1995-06-02 | Imaje Sa | Circuit d'encre notamment destine a la mise en pression d'une encre a pigments pour imprimante a jet d'encre. |
US5192746A (en) | 1990-07-09 | 1993-03-09 | Tanabe Seiyaku Co., Ltd. | Cyclic cell adhesion modulation compounds |
US5258402A (en) | 1992-06-11 | 1993-11-02 | Mcneil-Ppc, Inc. | Imidate derivatives of pharmaceutically useful anticonvulsant sulfamates |
US5432163A (en) | 1992-11-13 | 1995-07-11 | Greenwich Pharmaceuticals Incorporated | Anti-proliferative and anti-inflammatory compounds: derivatives of pentose monosaccharides |
US5637570A (en) * | 1995-05-09 | 1997-06-10 | Chemora Pharmochem | Disubstituted and trisubstituted derivatives of 2,3:4,6-di-O-isopropylidene-α-L-xylo-2-hexulofuranosonic acid having anti-cancer, anti-inflammatory and anti-proliferative activity |
IN190975B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1999-01-15 | 2003-09-06 | Ranbaxy Lab Ltd |
-
1999
- 1999-01-15 IN IN86DE1999 patent/IN190975B/en unknown
- 1999-03-25 US US09/276,368 patent/US6590085B1/en not_active Expired - Fee Related
-
2000
- 2000-01-10 TR TR2001/02043T patent/TR200102043T2/xx unknown
- 2000-01-10 CZ CZ20012540A patent/CZ20012540A3/cs unknown
- 2000-01-10 BR BR0007553-1A patent/BR0007553A/pt not_active IP Right Cessation
- 2000-01-10 AU AU18861/00A patent/AU768511B2/en not_active Ceased
- 2000-01-10 HU HU0105116A patent/HUP0105116A3/hu unknown
- 2000-01-10 ID IDW00200101520A patent/ID30351A/id unknown
- 2000-01-10 EP EP00900088A patent/EP1147119B1/en not_active Expired - Lifetime
- 2000-01-10 SK SK10132001A patent/SK284241B6/sk unknown
- 2000-01-10 PT PT00900088T patent/PT1147119E/pt unknown
- 2000-01-10 CA CA002359986A patent/CA2359986A1/en not_active Abandoned
- 2000-01-10 NZ NZ512852A patent/NZ512852A/xx unknown
- 2000-01-10 WO PCT/IB2000/000022 patent/WO2000042054A1/en active IP Right Grant
- 2000-01-10 CN CNB008048525A patent/CN1167707C/zh not_active Expired - Fee Related
- 2000-01-10 ES ES00900088T patent/ES2206176T3/es not_active Expired - Lifetime
- 2000-01-10 HR HR20010529A patent/HRP20010529B1/xx not_active IP Right Cessation
- 2000-01-10 MX MXPA01007187A patent/MXPA01007187A/es not_active IP Right Cessation
- 2000-01-10 NZ NZ527483A patent/NZ527483A/en unknown
- 2000-01-10 YU YU50701A patent/YU50701A/sh unknown
- 2000-01-10 AT AT00900088T patent/ATE250074T1/de not_active IP Right Cessation
- 2000-01-10 AR ARP000100086A patent/AR022235A1/es not_active Application Discontinuation
- 2000-01-10 JP JP2000593621A patent/JP2002534530A/ja active Pending
- 2000-01-10 DK DK00900088T patent/DK1147119T3/da active
- 2000-01-10 DE DE60005300T patent/DE60005300T2/de not_active Expired - Fee Related
- 2000-01-14 CO CO00001575A patent/CO5180591A1/es not_active Application Discontinuation
- 2000-01-14 MY MYPI20000121A patent/MY121135A/en unknown
- 2000-01-14 PA PA20008489901A patent/PA8489901A1/es unknown
-
2001
- 2001-07-12 MA MA26266A patent/MA25342A1/fr unknown
- 2001-07-12 CR CR6423A patent/CR6423A/xx not_active Application Discontinuation
- 2001-07-26 BG BG105745A patent/BG105745A/xx unknown
-
2003
- 2003-07-01 US US10/610,719 patent/US7037899B2/en not_active Expired - Fee Related
- 2003-07-01 US US10/611,091 patent/US20040018995A1/en not_active Abandoned
- 2003-07-01 US US10/611,093 patent/US7005422B2/en not_active Expired - Fee Related
- 2003-07-01 US US10/611,386 patent/US7005516B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20022649D0 (no) | Heterocykliske dihydropyrimidiner som kaliumkanal inhibitorer | |
DK1049662T3 (da) | Inhibitorer af alpha4-medieret celleadhæsion | |
NO20012701D0 (no) | Aryl- og heterosyklylsubstituerte pyrimidinderivater som antikoagulanter | |
NO20014642L (no) | Aminopyrimidiner som sorbitol-dehydrogenase-inhibitorer | |
DK2253620T3 (da) | Substituerede 3-cyanoquinoliner som protein-tyrosinkinase-inhibitorer | |
DK1244647T3 (da) | Quinzolinderivater som VIGF-inhibitorer | |
NO20022573D0 (no) | N6-heterosykliske, 8-modifiserte adenosinderivater | |
NO20001687D0 (no) | Benzamidinderivater som faktor Xa-inhibitorer | |
FI951001A7 (fi) | Sulfatoituja alfa-glykolipidijohdannaisia soluadheesioinhibiittoreina | |
DK1100797T3 (da) | Heterocycliske forbindelser som inhibitorer af rotamaseenzymer | |
DK1144425T3 (da) | Derivater af monosaccharider som celleadhæsionsinhibitorer | |
DK1060178T3 (da) | Heterocyklisk forbindelser som inhibitorer af rotamase enzymer | |
NO20050665L (no) | Pyrrolidonderivater som MAOE inhibitoere | |
NO20022125D0 (no) | Pyrrolderivater som inhibitorer for fosfodiesterase VII | |
DK1226143T3 (da) | Imidazopyridinderivater som phosphodiesterase VII-inhibitorer | |
NO20016201D0 (no) | Tienopyrimidiner som fosfodiesteraseinhibitorer | |
DK1228073T3 (da) | Imidazolforbindelser som phosphodiesterase VII-inhibitorer | |
DK1104762T3 (da) | Substituerede imidazo[1,2a]aziner som selektive COX-2-inhibitorer | |
DK1147119T3 (da) | 2,3-O-isopropylidenderivater af monosaccharider som celleadhæsionsinhibitorer | |
NO20021959L (no) | Tetrahydrotiopyranftalazinon-derivater som PDE4-inhibitorer | |
NO20016403L (no) | Substituerte purinderivater som inhibitorer av celleadhesjon | |
NO20014234D0 (no) | Pyrazol-3-on-derivater som faktor-Xa-inhibitorer | |
DK1222193T3 (da) | Imidazolderivater som phosphodiesterase VII-inhibitorer | |
EP1389200A4 (en) | SUBSTITUTED N-ARYLSULFONYL-PROLINE DERIVATIVES AS POWERFUL INHIBITORS OF CELL ADHESION | |
FI951002A7 (fi) | Sulfatoituja beta-glykolipidijohdannaisia soluadheesioinhibiittoreina |